Biomarkers in bipolar disorder: A positional paper from the International Society for Bipolar Disorders Biomarkers Task Force

Australian and New Zealand Journal of Psychiatry

Volumn 47, Issue 4, 2013, Pages 321-332

  Frey, Benicio N ^a   Andreazza, Ana C ^b   Houenou, Josselin ^c   Jamain, Stéphane ^d   Goldstein, Benjamin I ^b   Frye, Mark A ^e   Leboyer, Marion ^f   Berk, Michael ^g   Malhi, Gin S ^h   Lopez Jaramillo, Carlos ⁱ   Taylor, Valerie H ^b   Dodd, Seetal ^g   Frangou, Sophia ^j   Hall, Geoffrey B ^a   Fernandes, Brisa S ^k   Kauer Sant'Anna, Marcia ^k   Yatham, Lakshmi N ^l   Kapczinski, Flavio ^k   Young, L Trevor ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Hopital Albert Chenevier   (France)

^d INSERM U955   (France)

^e MAYO CLINIC   (United States)

^f UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h UNIVERSITY OF SYDNEY   (Australia)

ⁱ UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^j KING'S COLLEGE LONDON   (United Kingdom)

^k FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^l UNIVERSITY OF BRITISH COLUMBIA   (Canada)

more..

Author keywords

Biomarkers; Bipolar disorder; Inflammation; Neutrophins; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LAMOTRIGINE; LITHIUM; MESSENGER RNA; RILUZOLE; TUMOR NECROSIS FACTOR ALPHA;

AMYGDALOID NUCLEUS; BASAL GANGLION; BIPOLAR DISORDER; BRAIN SIZE; CALCIUM METABOLISM; CEREBELLUM; CIRCADIAN RHYTHM; DIFFUSION TENSOR IMAGING; FUNCTIONAL GENOMICS; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GRAY MATTER; GRAY MATTER VOLUME; HIPPOCAMPUS; HUMAN; INFLAMMATION; LIPID PEROXIDATION; MIDDLE FRONTAL GYRUS; MULTIFACTORIAL INHERITANCE; NERVE CELL DIFFERENTIATION; NEUROIMAGING; NONHUMAN; OXIDATIVE STRESS; PARAHIPPOCAMPAL GYRUS; PREFRONTAL CORTEX; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SIDE EFFECT; THALAMUS; TRANSCRIPTOMICS;

ADVISORY COMMITTEES; BIOLOGICAL MARKERS; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION MEDIATORS; NEUROIMAGING; OXIDATIVE STRESS;

EID: 84880530104     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867413478217     Document Type: Review

References (147)

1. Adler CM, Adams J, DelBello MP, et al. (2006) Evidence of white matter pathology in bipolar disorder adolescents experiencing their first episode of mania: A diffusion tensor imaging study. American Journal of Psychiatry 163: 322-324.
2. Adler CM, Holland SK, Schmithorst V, et al. (2004) Abnormal frontal white matter tracts in bipolar disorder: A diffusion tensor imaging study. Bipolar Disorders 6: 197-203.
3. Almeida JR, Versace A, Hassel S, et al. (2010) Elevated amygdala activity to sad facial expressions: A state marker of bipolar but not unipolar depression. Biological Psychiatry 67: 414-421.
4. Andreazza AC, Cassini C, Rosa AR, et al. (2007) Serum S100B and antioxidant enzymes in bipolar patients. Journal of Psychiatric Research 41: 523-529.
5. Andreazza AC, Kauer-Sant'anna M, Frey BN, et al. (2008) Oxidative stress markers in bipolar disorder: A meta-analysis. Journal of Affective Disorders 111: 135-144.
6. Athanasiu L, Mattingsdal M, Kahler AK, et al. (2010) Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. Journal of Psychiatric Research 44: 748-753.
7. Auer DP, Putz B, Kraft E, et al. (2000) Reduced glutamate in the anterior cingulate cortex in depression: An in vivo proton magnetic resonance spectroscopy study. Biological Psychiatry 47: 305-313.
8. Baumer FM, Howe M, Gallelli K, et al. (2006) A pilot study of antidepressant- induced mania in pediatric bipolar disorder: Characteristics, risk factors, and the serotonin transporter gene. Biological Psychiatry 60: 1005-1012.
9. Bearden CE, Thompson PM, Dutton RA, et al. (2008) Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder. Neuropsychopharmacology 33: 1229- 1238.
10. Benedetti F, Absinta M, Rocca MA, et al. (2011) Tract-specific white matter structural disruption in patients with bipolar disorder. Bipolar Disorders 13: 414-424.
11. Berger GE, Wood S and McGorry PD (2003) Incipient neurovulnerability and neuroprotection in early psychosis. Psychopharmacology Bulletin 37: 79-101.
12. Berk M, Copolov DL, Dean O, et al. (2008) N-acetyl cysteine for depressive symptoms in bipolar disorder-A double-blind randomized placebo- controlled trial. Biological Psychiatry 64: 468-475.
13. Berk M, Kapczinski F, Andreazza AC, et al. (2011) Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors. Neuroscience and Biobehavioral Reviews 35: 804-817.
14. Beyer JL, Taylor WD, MacFall JR, et al. (2005) Cortical white matter microstructural abnormalities in bipolar disorder. Neuropsychopharmacology 30: 2225-2229.
15. Biernacka JM, McElroy SL, Crow S, et al. (2012) Pharmacogenomics of antidepressant induced mania: A review and meta-analysis of the serotonin transporter gene (5HTTLPR) association. Journal of Affective Disorders 136: e21-29.
16. Bigos KL, Mattay VS, Callicott JH, et al. (2010) Genetic variation in CACNA1C affects brain circuitries related to mental illness. Archives of General Psychiatry 67: 939-945.
17. Birmaher B, Axelson D, Monk K, et al. (2009) Lifetime psychiatric disorders in school-aged offspring of parents with bipolar disorder: The Pittsburgh Bipolar Offspring study. Archives of General Psychiatry 66: 287-296.
18. Brennan BP, Hudson JI, Jensen JE, et al. (2010) Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole. Neuropsychopharmacology 35: 834-846.
19. Brietzke E, Stertz L, Fernandes BS, et al. (2009) Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. Journal of Affective Disorders 116: 214-217.
20. Brotman MA, Guyer AE, Lawson ES, et al. (2008) Facial emotion labeling deficits in children and adolescents at risk for bipolar disorder. American Journal of Psychiatry 165: 385-389.
21. Caetano SC, Olvera RL, Glahn D, et al. (2005) Fronto-limbic brain abnormalities in juvenile onset bipolar disorder. Biological Psychiatry 58: 525-531.
22. Carroll BJ, Feinberg M, Greden JF, et al. (1981) A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Archives of General Psychiatry 38: 15-22.
23. Chang K, Adleman NE, Dienes K, et al. (2004) Anomalous prefrontalsubcortical activation in familial pediatric bipolar disorder: A functional magnetic resonance imaging investigation. Archives of General Psychiatry 61: 781-792.
24. Chen CH, Suckling J, Lennox BR, et al. (2011) A quantitative meta-analysis of fMRI studies in bipolar disorder. Bipolar Disorders 13: 1-15.
25. Cunha AB, Frey BN, Andreazza AC, et al. (2006) Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neuroscience Letters 398: 215-219.
26. Dager SR, Friedman SD, Parow A, et al. (2004) Brain metabolic alterations in medication-free patients with bipolar disorder. Archives of General Psychiatry 61: 450-458.
27. Dao DT, Mahon PB, Cai X, et al. (2010) Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans. Biological Psychiatry 68: 801-810.
28. De Gonzalo-Calvo D, Neitzert K, Fernandez M, et al. (2010) Differential inflammatory responses in aging and disease: TNF-alpha and IL-6 as possible biomarkers. Free Radical Biology & Medicine 49: 733-737.
29. De Kloet ER, Joels M and Holsboer F (2005) Stress and the brain: from adaptation to disease. Nature Reviews. Neuroscience 6: 463-475.
30. De Oliveira GS, Cereser KM, Fernandes BS, et al. (2009) Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. Journal of Psychiatric Research 43: 1171-1174.
31. De Sousa RT, van de Bilt MT, Diniz BS, et al. (2011) Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: A preliminary 4-week study. Neuroscience Letters 494: 54-56.
32. Dickstein DP, Rich BA, Roberson-Nay R, et al. (2007) Neural activation during encoding of emotional faces in pediatric bipolar disorder. Bipolar Disorders 9: 679-692.
33. Drapier D, Surguladze S, Marshall N, et al. (2008) Genetic liability for bipolar disorder is characterized by excess frontal activation in response to a working memory task. Biological Psychiatry 64: 513-520.
34. Drexhage RC, van der Heul-Nieuwenhuijsen L, Padmos RC, et al. (2010) Inflammatory gene expression in monocytes of patients with schizophrenia: Overlap and difference with bipolar disorder. A study in naturalistically treated patients. The International Journal of Neuropsychopharmacology 13: 1369-1381.
35. Duffy A, Lewitzka U, Doucette S, et al. (2012) Biological indicators of illness risk in offspring of bipolar parents: Targeting the hypothalamic- pituitary-adrenal axis and immune system. Early Intervention in Psychiatry 6: 128-137.
36. Faraone SV, Glatt SJ and Tsuang MT (2003) The genetics of pediatriconset bipolar disorder. Biological Psychiatry 53: 970-977.
37. Feltes BC, de Faria Poloni J and Bonatto D (2011) The developmental aging and origins of health and disease hypotheses explained by different protein networks. Biogerontology 12: 293-308.
38. Fernandes BS, Gama CS, Maria Cereser K, et al. (2011) Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis. Journal of Psychiatric Research 45: 995-1004.
39. Ferreira MA, O'Donovan MC, Meng YA, et al. (2008) Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nature Genetics 40: 1056-1058.
40. Foland LC, Altshuler LL, Sugar CA, et al. (2008) Increased volume of the amygdala and hippocampus in bipolar patients treated with lithium. Neuroreport 19: 221-224.
41. Frank R and Hargreaves R (2003) Clinical biomarkers in drug discovery and development. Nature Reviews. Drug Discovery 2: 566-580.
42. Franke B, Vasquez AA, Veltman JA, et al. (2010) Genetic variation in CACNA1C, a gene associated with bipolar disorder, influences brainstem rather than gray matter volume in healthy individuals. Biological Psychiatry 68: 586-588.
43. Frey BN, Andreazza AC, Kunz M, et al. (2007) Increased oxidative stress and DNA damage in bipolar disorder: A twin-case report. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31: 283-285.
44. Frye MA, Watzl J, Banakar S, et al. (2007) Increased anterior cingulate/ medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology 32: 2490-2499.
45. Gallelli KA, Wagner CM, Karchemskiy A, et al. (2005) N-acetylaspartate levels in bipolar offspring with and at high-risk for bipolar disorder. Bipolar Disorders 7: 589-597.
46. Gargus JJ (2006) Ion channel functional candidate genes in multigenic neuropsychiatric disease. Biological Psychiatry 60: 177-185.
47. Geller B and Cook EH Jr (2000) Ultradian rapid cycling in prepubertal and early adolescent bipolarity is not in transmission disequilibrium with val/met COMT alleles. Biological Psychiatry 47: 605-609.
48. Geller B, Badner JA, Tillman R, et al. (2004) Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. American Journal of Psychiatry 161: 1698-1700.
49. Geller B, Tillman R, Bolhofner K, et al. (2006) Controlled, blindly rated, direct-interview family study of a prepubertal and early-adolescent bipolar I disorder phenotype: Morbid risk, age at onset, and comorbidity. Archives in General Psychiatry 63: 1130-1138.
50. Gergerlioglu HS, Savas HA, Bulbul F, et al. (2007) Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31: 697-702.
51. Godbout JP and Johnson RW (2004) Interleukin-6 in the aging brain. Journal of Neuroimmunology 147: 141-144.
52. Goldstein BI (2012) Recent progress in understanding pediatric bipolar disorder. Archives of Pediatrics & Adolescent Medicine 166: 362-371.
53. Goldstein BI, Collinger KA, Lotrich F, et al. (2011) Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders. Journal of Child and Adolescent Psychopharmacology 21: 479-484.
54. Gootjes L, Teipel SJ, Zebuhr Y, et al. (2004) Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging. Dementia and Geriatric Cognitive Disorders 18: 180-188.
55. Grande I, Fries GR, Kunz M, et al. (2010) The role of BDNF as a mediator of neuroplasticity in bipolar disorder. Psychiatry Investigation 7: 243-250.
56. Grande I, Kapczinski F, Stertz L, et al. (2012) Peripheral brain-derived neurotrophic factor changes along treatment with extended release quetiapine during acute mood episodes: An open-label trial in drugfree patients with bipolar disorder. Journal of Psychiatric Research 46: 1511-1514.
57. Green EK, Grozeva D, Jones I, et al. (2010) The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Molecular Psychiatry 15: 1016-1022.
58. Hajek T, Bernier D, Slaney C, et al. (2008) A comparison of affected and unaffected relatives of patients with bipolar disorder using proton magnetic resonance spectroscopy. Journal of Psychiatry and Neuroscience 33: 531-540.
59. Hallahan B, Newell J, Soares JC, et al. (2011) Structural magnetic resonance imaging in bipolar disorder: An international collaborative mega-analysis of individual adult patient data. Biological Psychiatry 69: 326-335.
60. Haznedar MM, Roversi F, Pallanti S, et al. (2005) Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses. Biological Psychiatry 57: 733-742.
61. Herberth M, Koethe D, Levin Y, et al. (2011) Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival. Proteomics 11: 94-105.
62. Holsboer F (2000) The stress hormone system is back on the map. Current Psychiatry Reports 2: 454-456.
63. Houenou J, Frommberger J, Carde S, et al. (2011) Neuroimaging-based markers of bipolar disorder: Evidence from two meta-analyses. Journal of Affective Disorders 132: 344-355.
64. Houenou J, Wessa M, Douaud G, et al. (2007) Increased white matter connectivity in euthymic bipolar patients: Diffusion tensor tractography between the subgenual cingulate and the amygdalo-hippocampal complex. Molecular Psychiatry 12: 1001-1010.
65. International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, et al (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460: 748-752.
66. Iwamoto K, Kakiuchi C, Bundo M, et al. (2004) Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Molecular Psychiatry 9: 406-416.
67. Jogia J, Ruberto G, Lelli-Chiesa G, et al. (2011) The impact of the CACNA1C gene polymorphism on frontolimbic function in bipolar disorder. Molecular Psychiatry 16: 1070-1071.
68. Kapczinski F, Dal-Pizzol F, Teixeira AL, et al. (2011) Peripheral biomarkers and illness activity in bipolar disorder. Journal of Psychiatric Research 45: 156-161.
69. Kato T, Hayashi-Takagi A, Toyota T, et al. (2011) Gene expression analysis in lymphoblastoid cells as a potential biomarker of bipolar disorder. Journal of Human Genetics 56: 779-783.
70. Kauer-Sant'Anna M, Kapczinski F, Andreazza AC, et al. (2009) Brainderived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. International Journal of Neuropsychopharmacology 12: 447-458.
71. Kempton MJ, Geddes JR, Ettinger U, et al. (2008) Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Archives of General Psychiatry 65: 1017-1032.
72. Kempton MJ, Ruberto G, Vassos E, et al. (2009) Effects of the CACNA1C risk allele for bipolar disorder on cerebral gray matter volume in healthy individuals. American Journal of Psychiatry 166: 1413-1414.
73. Kim YK, Jung HG, Myint AM, et al. (2007) Imbalance between proinflammatory and anti-inflammatory cytokines in bipolar disorder. Journal of Affective Disorders 104: 91-95.
74. Kutcher S and Sokolov S (1995) Adolescent depression: Neuroendocrine aspects. In: Goodyer IM (ed) The Depressed Child and Adolescent. Cambridge: Cambridge University Press, pp.195-224.
75. Leboyer M, Soreca I, Scott J, et al. (2012) Can bipolar disorder be viewed as a multi-system inflammatory disease? Journal of Affective Disorders 141: 1-10.
76. Leibenluft E, Rich BA, Vinton DT, et al. (2007) Neural circuitry engaged during unsuccessful motor inhibition in pediatric bipolar disorder. American Journal of Psychiatry 164: 52-60.
77. Le-Niculescu H, Patel SD, Bhat M, et al. (2009) Convergent functional genomics of genome-wide association data for bipolar disorder: Comprehensive identification of candidate genes, pathways and mechanisms. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 150B: 155-181.
78. Liu Y, Blackwood DH, Caesar S, et al. (2011) Meta-analysis of genomewide association data of bipolar disorder and major depressive disorder. Molecular Psychiatry 16: 2-4.
79. Machado-Vieira R, Andreazza AC, Viale CI, et al. (2007a) Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: A possible role for lithium antioxidant effects. Neuroscience Letters 421: 33-36.
80. Machado-Vieira R, Dietrich MO, Leke R, et al. (2007b) Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biological Psychiatry 61: 142-144.
81. Magalhaes PV, Dean OM, Bush AI, et al. (2011) N-acetyl cysteine addon treatment for bipolar II disorder: A subgroup analysis of a randomized placebo-controlled trial. Journal of Affective Disorders 129: 317-320.
82. Maj M, Ariano MG, Arena F, et al. (1984) Plasma cortisol, catecholamine and cyclic AMP levels, response to dexamethasone suppression test and platelet MAO activity in manic-depressive patients. A longitudinal study. Neuropsychobiology 11: 168-173.
83. Meyer-Lindenberg A (2010) Behavioural neuroscience: Genes and the anxious brain. Nature 466: 827-828.
84. Mick E and Faraone SV (2009) Family and genetic association studies of bipolar disorder in children. Child and Adolescent Psychiatric Clinics of North America 18: 441-453, x.
85. Moore GJ, Bebchuk JM, Hasanat K, et al. (2000) Lithium increases N-acetyl-aspartate in the human brain: In vivo evidence in support of bcl-2's neurotrophic effects? Biological Psychiatry 48: 1-8.
86. Moore GJ, Cortese BM, Glitz DA, et al. (2009) A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. Journal of Clinical Psychiatry 70: 699-705.
87. Nakatani N, Hattori E, Ohnishi T, et al. (2006) Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: Relevance to neuronal network perturbation. Human Molecular Genetics 15: 1949-1962.
88. Nyegaard M, Demontis D, Foldager L, et al. (2010) CACNA1C (rs1006737) is associated with schizophrenia. Molecular Psychiatry 15: 119-121.
89. O'Brien SM, Scully P, Scott LV, et al. (2006) Cytokine profiles in bipolar affective disorder: Focus on acutely ill patients. Journal of Affective Disorders 90: 263-267.
90. O'Donovan MC, Craddock NJ and Owen MJ (2009) Genetics of psychosis; insights from views across the genome. Human Genetics 126: 3-12.
91. Ongur D, Jensen JE, Prescot AP, et al. (2008) Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biological Psychiatry 64: 718-726.
92. Ozcan ME, Gulec M, Ozerol E, et al. (2004) Antioxidant enzyme activities and oxidative stress in affective disorders. International Clinical Psychopharmacology 19: 89-95.
93. Padmos RC, Hillegers MH, Knijff EM, et al. (2008) A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Archives of General Psychiatry 65: 395-407.
94. Pandey GN, Rizavi HS, Dwivedi Y, et al. (2008) Brain-derived neurotrophic factor gene expression in pediatric bipolar disorder: Effects of treatment and clinical response. Journal of the American Academy of Child and Adolescent Psychiatry 47: 1077-1085.
95. Pariante CM (2004) Glucocorticoid receptor function in vitro in patients with major depression. Stress 7: 209-219.
96. Pasco JA, Jacka FN, Williams LJ, et al. (2010) Clinical implications of the cytokine hypothesis of depression: The association between use of statins and aspirin and the risk of major depression. Psychotherapy and Psychosomatics 79: 323-325.
97. Patel NC, DelBello MP, Cecil KM, et al. (2006) Lithium treatment effects on Myo-inositol in adolescents with bipolar depression. Biological Psychiatry 60: 998-1004.
98. Patel NC, DelBello MP, Cecil KM, et al. (2008) Temporal change in N-acetyl-aspartate concentrations in adolescents with bipolar depression treated with lithium. Journal of Child and Adolescent Psychopharmacology 18: 132-139.
99. Pavuluri MN, O'Connor MM, Harral E, et al. (2007) Affective neural circuitry during facial emotion processing in pediatric bipolar disorder. Biological Psychiatry 62: 158-167.
100. Perrier E, Pompei F, Ruberto G, et al. (2011) Initial evidence for the role of CACNA1C on subcortical brain morphology in patients with bipolar disorder. European Psychiatry 26: 135-137.
101. Pfeifer JC, Welge J, Strakowski SM, et al. (2008) Meta-analysis of amygdala volumes in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry 47: 1289-1298.
102. Pfleiderer B, Michael N, Erfurth A, et al. (2003) Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Research 122: 185-192.
103. Phillips ML, Drevets WC, Rauch SL, et al. (2003) Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biological Psychiatry 54: 515-528.
104. Phillips ML, Ladouceur CD and Drevets WC (2008) A neural model of voluntary and automatic emotion regulation: Implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Molecular Psychiatry 13: 829, 833-857.
105. Platman SR and Fieve RR (1968) Lithium carbonate and plasma cortisol response in the ffective disorders. Archives of General Psychiatry 18: 591-594.
106. Plotsky PM, Owens MJ and Nemeroff CB (1998) Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. The Psychiatric Clinics of North America 21: 293-307.
107. Pompei F, Jogia J, Tatarelli R, et al. (2011) Familial and disease specific abnormalities in the neural correlates of the Stroop Task in Bipolar Disorder. Neuroimage 56: 1677-1684.
108. Port JD, Unal SS, Mrazek DA, et al. (2008) Metabolic alterations in medication- free patients with bipolar disorder: A 3T CSF-corrected magnetic resonance spectroscopic imaging study. Psychiatry Research 162: 113-121.
109. Post RM (2007) Role of BDNF in bipolar and unipolar disorder: Clinical and theoretical implications. Journal of Psychiatric Research 41: 979-990.
110. Price RB, Shungu DC, Mao X, et al. (2009) Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: Relationship to treatment resistance in major depressive disorder. Biological Psychiatry 65: 792-800.
111. Psychiatric GWAS Consortium Bipolar Disorder Working Group (2011) Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nature Genetics 43: 977-983.
112. Regenold WT, D'Agostino CA, Ramesh N, et al. (2006) Diffusionweighted magnetic resonance imaging of white matter in bipolar disorder: A pilot study. Bipolar Disorders 8: 188-195.
113. Ruberto G, Vassos E, Lewis CM, et al. (2011) The cognitive impact of the ANK3 risk variant for bipolar disorder: Initial evidence of selectivity to signal detection during sustained attention. PLoS One 6: e16671.
114. Ryan MM, Lockstone HE, Huffaker SJ, et al. (2006) Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Molecular Psychiatry 11: 965-978.
115. Savas HA, Gergerlioglu HS, Armutcu F, et al. (2006) Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: Impact of past episodes. World Journal of Biological Psychiatry 7: 51-55.
116. Savas HA, Herken H, Yurekli M, et al. (2002) Possible role of nitric oxide and adrenomedullin in bipolar affective disorder. Neuropsychobiology 45: 57-61.
117. Savitz J and Drevets WC (2009) Bipolar and major depressive disorder: Neuroimaging the developmental-degenerative divide. Neuroscience and Biobehavioral Reviews 33: 699-771.
118. Savitz J, Nugent AC, Bogers W, et al. (2010) Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: The impact of medication. Neuroimage 49: 2966-2976.
119. Schulze TG, Detera-Wadleigh SD, Akula N, et al. (2009) Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Molecular Psychiatry 14: 487-491.
120. Schunemann HJ, Oxman AD, Brozek J, et al. (2008) Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 336: 1106-1110.
121. Scott LJ, Muglia P, Kong XQ, et al. (2009) Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proceedings of the National Academy of Sciences of the United States of America 106: 7501-7506.
122. Selek S, Savas HA, Gergerlioglu HS, et al. (2008) The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. Journal of Affective Disorders 107: 89-94.
123. Sequeira A and Turecki G (2006) Genome wide gene expression studies in mood disorders. Omics: A Journal of Integrative Biology 10: 444-454.
124. Sklar P, Smoller JW, Fan J, et al. (2008) Whole-genome association study of bipolar disorder. Molecular Psychiatry 13: 558-569.
125. Stork C and Renshaw PF (2005) Mitochondrial dysfunction in bipolar disorder: Evidence from magnetic resonance spectroscopy research. Molecular Psychiatry 10: 900-919.
126. Strakowski SM, Delbello MP and Adler CM (2005) The functional neuroanatomy of bipolar disorder: A review of neuroimaging findings. Molecular Psychiatry 10: 105-116.
127. Strakowski SM, Eliassen JC, Lamy M, et al. (2011) Functional magnetic resonance imaging brain activation in bipolar mania: Evidence for disruption of the ventrolateral prefrontal-amygdala emotional pathway. Biological Psychiatry 69: 381-388.
128. Sussulini A, Dihazi H, Banzato CE, et al. (2011) Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder. Proteomics 11: 261-269.
129. Takata A, Kim SH, Ozaki N, et al. (2011) Association of ANK3 with bipolar disorder confirmed in East Asia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 156B: 312-315.
130. Thermenos HW, Goldstein JM, Milanovic SM, et al. (2010) An fMRI study of working memory in persons with bipolar disorder or at genetic risk for bipolar disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153B: 120-131.
131. Tkachev D, Mimmack ML, Ryan MM, et al. (2003) Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362: 798-805.
132. Tramontina JF, Andreazza AC, Kauer-Sant'anna M, et al. (2009) Brainderived neurotrophic factor serum levels before and after treatment for acute mania. Neuroscience Letters 452: 111-113.
133. Tsuang MT, Nossova N, Yager T, et al. (2005) Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: A preliminary report. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 133B: 1-5.
134. Vacher H, Mohapatra DP and Trimmer JS (2008) Localization and targeting of voltage-dependent ion channels in mammalian central neurons. Physiological Reviews 88: 1407-1447.
135. Van der Werf-Eldering MJ, Riemersma-van der Lek RF, Burger H, et al. (2012) Can variation in hypothalamic-pituitary-adrenal (HPA)-axis activity explain the relationship between depression and cognition in bipolar patients? PLoS One 7: e37119.
136. Van Lieshout R and Szatmari P (2009) Methodological and statistical issues in the use of biomarkers in clinical and research studies. In: Ritsner MS (ed) The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes. Dordrecht: Springer Science and Business Media BV., pp.23-39.
137. Vasan RS (2006) Biomarkers of cardiovascular disease: Molecular basis and practical considerations. Circulation 113: 2335-2362.
138. Versace A, Almeida JR, Quevedo K, et al. (2010) Right orbitofrontal corticolimbic and left corticocortical white matter connectivity differentiate bipolar and unipolar depression. Biological Psychiatry 68: 560-567.
139. Walter M, Henning A, Grimm S, et al. (2009) The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression. Archives of General Psychiatry 66: 478-486.
140. Weiner M, Warren L and Fiedorowicz JG (2011) Cardiovascular morbidity and mortality in bipolar disorder. Annals of Clinical Psychiatry 23: 40-47.
141. Wessa M, Linke J, Witt SH, et al. (2010) The CACNA1C risk variant for bipolar disorder influences limbic activity. Molecular Psychiatry 15: 1126-1127.
142. Yang S, Van Dongen HP, Wang K, et al. (2009) Assessment of circadian function in fibroblasts of patients with bipolar disorder. Molecular Psychiatry 14: 143-155.
143. Yanik M, Vural H, Tutkun H, et al. (2004) The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder. European Archives of Psychiatry and Clinical Neuroscience 254: 43-47.
144. Yatham LN, Kapczinski F, Andreazza AC, et al. (2009) Accelerated agerelated decrease in brain-derived neurotrophic factor levels in bipolar disorder. International Journal of Neuropsychopharmacology 12: 137-139.
145. Youngstrom EA, Birmaher B and Findling RL (2008) Pediatric bipolar disorder: Validity, phenomenology, and recommendations for diagnosis. Bipolar Disorders 10: 194-214.
146. Yucel K, Taylor VH, McKinnon MC, et al. (2008) Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment. Neuropsychopharmacology 33: 361-367.
147. Yuksel C and Ongur D (2010) Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biological Psychiatry 68: 785-794.